Grupo Elfa

Based in Brazil, Grupo Elfa operates as a supplier of pharmaceuticals and medical products, enhancing healthcare delivery across the nation through efficient logistics and a diverse service portfolio. Grupo Elfa, founded in 1989 in Joao Pessoa, Brazil, specializes in the distribution of healthcare products. The company has completed 4 deals, with its most recent deal occurring on July 10, 2023, during a GROWTH funding round where it raised BRL 620 million from Patria Investments, marking the total amount raised at BRL 620 million. The leadership team is composed of CEO Andrés Cima and others including Bruno Zanni, Leonardo Pelloso, and Rafael Tobara.

Grupo Elfa specializes in a comprehensive range of products and services aimed at enhancing health outcomes across Brazil. The company’s core offerings include the distribution of pharmaceuticals and provision of medical and hospital products and services. By connecting services throughout the healthcare supply chain, Grupo Elfa ensures a diverse selection that meets the needs of healthcare providers, hospitals, clinics, and individual patients. Their logistics solutions are designed to function efficiently across the entire national territory, facilitating timely access to essential medications and medical supplies.

With a focus on operational excellence and technological innovation, Grupo Elfa serves millions of end users across Brazil, contributing significantly to the health sector's capability to deliver care effectively. Grupo Elfa operates on a business-to-business model, primarily engaging with healthcare providers, including hospitals, clinics, and pharmacies. The company reported a revenue of BRL 1,198,175,140. 60 for the year 2022, along with an EBITDA of BRL 82,973,751.

60 for the same period. Revenue generation is achieved through direct sales of its extensive portfolio of pharmaceuticals and medical supplies, with transactions structured to cater to bulk purchases and recurring orders. Partnerships with various healthcare entities bolster the company’s market presence, allowing for streamlined operations and enhanced service delivery. The pricing structure reflects the value of their flagship products and services, designed to be competitive within the healthcare supply market while ensuring accessibility for their client base.

In July 2023, Patria Investments invested BRL 620 million in Grupo Elfa. This investment is aimed at expanding the company's service offerings and geographic market presence through organic growth initiatives and acquisitions. Specific plans for future growth include the development of new products and exploring new geographical markets, although detailed timelines for these initiatives have not been disclosed.